Reprieve Cardiovascular Funding: $103M Raised, Series B
Reprieve Cardiovascular is based in Milford. It has raised $103M in total funding. Latest round: Series B.
Reprieve Cardiovascular funding overview
Reprieve Cardiovascular is based in Milford. Reprieve Cardiovascular has raised $103M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2025. The round record for Reprieve Cardiovascular runs through 2025; nothing later has been disclosed. Investors on record include Deerfield Management, Arboretum Ventures, Lightstone Ventures, Sante Ventures, Genesis Capital, Rex Health Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Reprieve Cardiovascular at a glance
Total raised
$103M
Latest round
Series B
Latest round date
August 2025
Headquarters
Milford
Notable investors
Deerfield Management, Arboretum Ventures, Lightstone Ventures, Sante Ventures, Genesis Capital, Rex Health Ventures, Cadence Capital
Frequently asked about Reprieve Cardiovascular funding
How much has Reprieve Cardiovascular raised?
Reprieve Cardiovascular has raised $103M in total disclosed funding across the rounds on record.
Who has invested in Reprieve Cardiovascular?
Deerfield Management, Arboretum Ventures, Lightstone Ventures, Sante Ventures, Genesis Capital, Rex Health Ventures are named among the investors backing Reprieve Cardiovascular.
What was the latest Reprieve Cardiovascular funding round?
The most recent disclosed round is a Series B, announced in August 2025.
Where is Reprieve Cardiovascular based?
Reprieve Cardiovascular is based in Milford.
When did Reprieve Cardiovascular last raise?
The last disclosed Reprieve Cardiovascular round closed in August 2025 at Series B.
Every Reprieve Cardiovascular figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Milford at a similar stage.
